Filed before 2025Filed 14 February 2024
NextPoint Therapeutics, Inc. raised $42.5M
NextPoint Therapeutics, Inc., a biotech company based in Cambridge, MA, raised $42.5M in a new equity round, according to a filing dated 14 February 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 14 February 2024
- Round
- Equity round
- Amount sold
- $42.5M
- Offering size
- $42.5M
- Investors so far
- 15
- Based in
- Cambridge, MA
- Website
- nextpointtx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 87% of the 1,434 tracked raises with an amount filed in 2024, and than 71% of the 138 in biotech.
NextPoint Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 30 Jul 2026 | New filing | $33.7M | Another raise |
| 14 Feb 2024 | New filing | $42.5M | This raise |
| 27 Dec 2022 | New filing | $80M | Another raise |
More with Catalio Nexus on the board
- Iambic Therapeutics, Inc.$66M
- ManaT Bio, Inc.$72.1M
- Haystack Oncology, Inc.$67M
- eNeura, INC.$511K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.